RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
GAIDANO G
Collezione AOU Novara
Items : 107
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.
2024
ASL Biella
AO Alessandria
AOU Città della Salute di Torino
AOU Novara
Zucca E; Vitolo U; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Ghiggi C; Pisani F; Zanni M; Liberati AM; Annibali O; Celli M; Bruna R; Orsucci L; Cabras MG; Tani M; Tucci A; Vanazzi A; Balzarotti M; Merli F; Stathis A; Gaidano G; Sassone M; Botto B; Conconi A; Chiappella A; Ferreri AJM; et alii...
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.
2024
AOU Novara
Sparano F; Giesinger JM; Gaidano G; Anota A; Cavo M; Brini A; Voso MT; Venditti A; Perrone F; Di Maio M; Luppi M; Baron F; Platzbecker U; Fazi P; Vignetti M; Efficace F;
Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi. in British journal of haematology / Br J Haematol. 2024 Jun 28. doi: 10.1111/bjh.19617.
2024
AOU Città della Salute di Torino
AOU Novara
Dodero A; Gaidano G; Fabbri A; Olivieri J; Arcaini L; Tani M; Zilioli VR; Visco C; Castiglione A; Re A; Lucchini E; Clerico M; Cavallo F; Zaja F;
Prescription patterns of venetoclax in acute myeloid leukemia. in Hematological oncology / Hematol Oncol. 2024 Jul;42(4):e3298. doi: 10.1002/hon.3298.
2024
AOU Novara
Ucciero A; Traversa G; Pisterna A; Cardinali V; Sciabolacci S; Poloni A; Capelli D; Gaidano G; Patriarca A; Lunghi M;
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.
2024
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
Molica S; Iannella E; Malgieri S; Gozzetti A; Gualberti G; Caira M; Finsinger P; Reda G; Coscia M; Vallisa D; Pane F; Cuneo A; Albano F; Zamprogna G; Trentin L; Mauro FR; Albi E; Gaidano G; Laurenti L; Sportoletti P; Chiarenza A;
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jan;35(1):118-129. doi: 10.1016/j.annonc.2023.10.095. Epub 2023 Nov 3.
2024
AO Alessandria
AOU Novara
AOU Città della Salute di Torino
Benedetti F; Luminari S; Vitolo U; Ferreri AJM; Latte G; Ciccone G; Bottelli C; Anastasia A; Boccomini C; Bossi E; Pennese E; Re F; Patti C; Pastore D; Cavallo F; Milone G; Ghiggi C; Pinto A; Corradini P; Tani M; Gaidano G; Zilioli VR; Pavone V; Arcari A; Puccini B; Volpetti S; Ferrero S; Tucci A; Botto B; et alii...
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies. in Cancers / Cancers (Basel). 2023 Sep 18;15(18):4618. doi: 10.3390/cancers15184618.
2023
AOU Novara
Patriarca A; Gaidano G; Barone-Adesi F; Pisterna A; Scotti L; Ucciero A; Pagnoni F; Lunghi M;
10-day decitabine versus 3?+?7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9.
2023
AOU Novara
AOU Città della Salute di Torino
Becker H; Blijlevens N; Wäsch R; Vilque JP; Ammatuna E; Efficace F; de Graaf AO; Stevens-Kroef M; Jansen JH; Hoogendoorn M; Giraut A; Posthuma EFM; van Lammeren-Venema D; Gaidano G; Foà R; Legrand O; Candoni A; Audisio E; Fuhrmann S; Luppi M; Vrhovac R; Crysandt M; Neubauer A; Griškevi?ius L; Noppeney R; Van der Velden WJFM; Chantepie S; Kicinski M; Wijermans PW; et alii...
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.
2023
AOU Novara
AOU Città della Salute di Torino
Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; Rigolin GM; et alii...
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. in Blood advances / Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821.
2023
AOU Città della Salute di Torino
AOU Novara
Scarfò L; Stamatopoulos K; Ranghetti P; Baliakas P; Cortese D; Österborg A; Walewska R; Pavlovsky C; Strugov V; Ysebaert L; Mulligan SP; Iyengar S; Coscia M; Frustaci AM; Jaksic O; Ringshausen I; Forconi F; Panayiotidis P; Marasca R; Tam CS; Stavroyianni N; Bödör C; Reda G; Trentin L; Bonello L; Gaidano G; Gandini F; Lyander A; Skaftason A; et alii...
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. in International journal of molecular sciences / Int J Mol Sci. 2023 Jun 20;24(12):10374. doi: 10.3390/ijms241210374.
2023
AOU Novara
Maher N; Mouhssine S; Matti BF; Alwan AF; Gaidano G;
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. in Haematologica / Haematologica. 2023 Jul 1;108(7):1793-1802. doi: 10.3324/haematol.2022.281563.
2023
AOU Novara
Pabst T; Vey N; Adès L; Bacher U; Bargetzi M; Fung S; Gaidano G; Gandini D; Hultberg A; Johnson A; Ma X; Müller R; Nottage K; Papayannidis C; Recher C; Riether C; Shah P; Tryon J; Xiu L; Ochsenbein AF;
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy. in Cancers / Cancers (Basel). 2023 Feb 5;15(4):1015. doi: 10.3390/cancers15041015.
2023
AOU Novara
Mahmoud AM; Gaidano G; Mouhssine S;
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. in American journal of hematology / Am J Hematol. 2023 Feb;98(2):E24-E27. doi: 10.1002/ajh.26779. Epub 2022 Nov 25.
2023
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Levi S; Trentin L; Foà R; Cuneo A; Herishanu Y; Gentile M; Perry C; Gattei V; Gaidano G; Rossi D; Neri A; Olivieri J; Bomben R; Zucchetto A; Visentin A; Loseto G; Pietrasanta D; Chiarenza A; Braester A; Murru R; Aviv A; Varettoni M; Coscia M; Tadmor T; Shvidel L; Sportoletti P; Laurenti L; Reda G; Ruchlemer R; et alii...
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy. in Haematologica / Haematologica. 2023 Aug 1;108(8):2101-2115. doi: 10.3324/haematol.2022.282177.
2023
AOU Città della Salute di Torino
AOU Novara
Ramsay AG; Deaglio S; D'Arena G; Allan JN; Furman RR; Vaisitti T; Laurenti L; Gaidano G; Coscia M; Ioannou N; Rossi D; Moia R; Iannello A; Papazoglou D; Arruga F; Rubin M;
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.
2023
AOU Novara
Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets. in Cancers / Cancers (Basel). 2022 Sep 24;14(19):4644. doi: 10.3390/cancers14194644.
2022
AOU Novara
Mouhssine S; Gaidano G;
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study. in The lancet. Healthy longevity / Lancet Healthy Longev. 2022 Sep;3(9):e628-e635. doi: 10.1016/S2666-7568(22)00172-6.
2022
AOU Città della Salute di Torino
AOU Novara
Cavo M; Vignetti M; Derudas D; Gozzetti A; Kyriakou C; Cascavilla N; Offidani M; Romano A; Pastore D; Rigolin GM; Potenza L; Fozza C; Larocca A; Tafuri A; Antonioli E; Codeluppi K; Cottone F; Petrucci MT; Niscola P; Gaidano G; Efficace F;
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module. in Hepatology communications / Hepatol Commun. 2022 Nov;6(11):3006-3014. doi: 10.1002/hep4.2070. Epub 2022 Sep 9.
2022
AOU Novara
Rigamonti C; Cittone MG; Manfredi GF; Sorge A; Moia R; Patriarca A; Donato MF; Gaidano G; Pirisi M; Fraquelli M;
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. in American journal of hematology / Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25.
2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara
Mauro FR; Trentin L; Foa' R; Tedeschi A; Gaidano G; Cuneo A; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Del Poeta G; Stelitano C; Moia R; Giordano A; Levato L; Rigolin GM; Gentile M; Murru R; De Paoli L; Laurenti L; Vitale C; Ciolli S; Chiarenza A; Sportoletti P; Frustaci AM; Visentin A; Reda G; Giannarelli D; et alii...
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. in British journal of haematology / Br J Haematol. 2022 Mar;196(5):1184-1193. doi: 10.1111/bjh.17971. Epub 2021 Dec 23.
2022
AO Alessandria
ASL Cuneo 1
AOU Città della Salute di Torino
AO Cuneo
AOU Novara
Vitolo U; Tucci A; Balzarotti M; Gaidano G; Pileri SA; Ladetto M; Righi S; Santambrogio E; Motta G; Moia R; Martelli M; Melle F; Di Rocco A; Evangelista A; Ciccone G; Agostinelli C; Novo M; Nassi L; Chiappella A; Diop F;
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes. in International journal of molecular sciences / Int J Mol Sci. 2022 Jul 7;23(14):7542. doi: 10.3390/ijms23147542.
2022
AOU Novara
Gallazzi M; Ucciero MAM; Faraci DG; Mahmoud AM; Al Essa W; Gaidano G; Mouhssine S; Crisà E;
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Jul 11;114(7):979-987. doi: 10.1093/jnci/djac057.
2022
AO Alessandria
AOU Novara
Ruiz-Camps I; Pinato DJ; Bower M; Diamantis N; Sinclair A; Colomba E; Tondini C; Maconi A; Betti M; Zambelli A; Guida A; Giusti R; Zoratto F; Queirolo P; Parisi A; Lambertini M; Tagliamento M; Mazzoni F; Tucci M; Berardi R; Generali D; Grisanti S; Provenzano S; Vincenzi B; Libertini M; Sanchez de Torre A; Rimassa L; Rossi S; Harbeck N; et alii...
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.
2022
AO Alessandria
AOU Novara
Tabernero J; Cortellini A; Provenzano S; Gennari A; Fusco V; Generali D; Grisanti S; Mukherjee U; Diamantis N; Libertini M; Tucci M; Prat A; Rimassa L; Aujayeb A; Grosso F; Parisi A; Queirolo P; Mazzoni F; Caliman E; Santoro A; Giusti R; Zambelli A; Cantini L; Martinez-Vila C; Patriarca A; Bruna R; Ruiz-Camps I; Gaidano G; Fox L; et alii...
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. in JAMA oncology / JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.
2022
AOU Novara
Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; et alii...
Genetic and phenotypic attributes of splenic marginal zone lymphoma. in Blood / Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386.
2022
AO Cuneo
AOU Novara
AO Alessandria
Rossi D; Ponzoni M; Mazzucchelli L; Zucca E; Cavalli F; Paulli M; Piris MA; Traverse-Glehen A; Tzankov A; Campo E; Pileri SA; Dirnhofer S; De Leval L; Bhagat G; Bertoni F; Zinzani PL; Khiabanian H; Zaja F; Calcinotto A; Zenz T; Vitolo U; Visco C; Walewska R; Vanini G; Tousseyn T; Tucci A; Tarella C; Thieblemont C; Tapia G; et alii...
Donor-derived acute myeloid leukemia in solid organ transplantation. in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons / Am J Transplant. 2022 Dec;22(12):3111-3119. doi: 10.1111/ajt.17174. Epub 2022 Sep 8.
2022
AOU Città della Salute di Torino
AOU Novara
Amoroso A; Saglio G; Gaidano G; Bruno B; Omar MN; Zanettini C; Imada EL; Berrino M; Stratta P; Deaglio S; Besso FG; Serra A; Kostadinov R; Lobo FP; Marchionni L;
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23.
2022
AO Alessandria
AOU Novara
Tabernero J; Cortellini A; Gennari A; Prat A; Rimassa L; Aujayeb A; Queirolo P; Delfanti S; Parisi A; Mazzoni F; Santoro A; Filetti M; Berardi R; Martinez-Vila C; Fusco V; Shawe-Taylor M; Patriarca A; Gaidano G; Ruiz-Camps I; Bruna R; Roldán E; Zoratto F; Fox L; Doonga K; Perachino M; Fort-Culillas R; Saoudi-Gonzalez N; Cruz CA; Yu T; et alii...
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study. in Advances in hematology / Adv Hematol. 2022 Jan 27;2022:5581772. doi: 10.1155/2022/5581772. eCollection 2022.
2022
AO Alessandria
AOU Novara
Martelli M; Barbiero V; Mengarelli A; Consoli U; Santoro A; Liberati AM; Ladetto M; Fraticelli V; Guarini A; Mannina D; Ferrando P; Corradini P; Musto P; Stelitano C; Ronci B; La Nasa G; Massimi S; Gaglione G; Cantore N; Inzoli A; Cardinale G; Cerqueti M; Turrini M; Arcaini L; Santini S; Ferreri AJM; Caparrotti G; Battistini R; Murineddu M; et alii...
Precision Medicine in Systemic Mastocytosis. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2021 Oct 20;57(11):1135. doi: 10.3390/medicina57111135.
2021
AOU Novara
Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E;
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. in HemaSphere / Hemasphere. 2021 Sep 6;5(10):e639. doi: 10.1097/HS9.0000000000000639. eCollection 2021 Oct.
2021
AOU Città della Salute di Torino
AOU Novara
Drandi D; Ferrero S; Ladetto M; Gaidano G; Del Giudice I; Galimberti S; Gattei V; Agostinelli C; Delfau-Larue MH; García-Sanz R; Pott C; Alessandria B; Degan M; Bomben R; Mannu C; Gazzola A; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Della Starza I; Ferrante M; Genuardi E; Mantoan B;
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study. in BMC geriatrics / BMC Geriatr. 2021 May 19;21(1):320. doi: 10.1186/s12877-021-02237-3.
2021
AOU Città della Salute di Torino
AOU Novara
Varughese F; Cappelli M; Burrafato G; Bruna R; Maggiora PM; Biello F; Mahmoud AM; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A;
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia. in The New England journal of medicine / N Engl J Med. 2021 May 13;384(19):1810-1823. doi: 10.1056/NEJMoa2031298.
2021
AOU Novara
Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B;
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Foà R; Ferrarini M; Polliack A; Gaidano G; Trentin L; Cuneo A; Fronza G; Cutrona G; Rossi D; Di Raimondo F; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; Caracciolo D; Cassin R; D'Arrigo G; Mendicino F; Botta C; Martino EA; Vigna E; Zucchetto A; Rossi FM; Scortechini I; et alii...
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists. in International journal of molecular sciences / Int J Mol Sci. 2021 Mar 3;22(5):2525. doi: 10.3390/ijms22052525.
2021
AOU Novara
Crisà E; Boggione P; Nicolosi M; Mahmoud AM; Al Essa W; Awikeh B; Aspesi A; Andorno A; Boldorini R; Dianzani I; Gaidano G; Patriarca A;
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. in Blood / Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.
2021
AOU Città della Salute di Torino
AOU Novara
Jelinek D; Haferlach C; Stilgenbauer S; Hallek M; Oscier D; Fischer K; Anagnostopoulos A; Pott C; Campo E; Niemann C; Francia di Celle P; Gaidano G; Stavroyianni N; Trentin L; Montillo M; Antic D; Foroni L; Espinet B; Costeas P; Panagiotidis P; Alshemmari S; Rossi D; Panovska I; Kater AP; Fais F; Bödör C; Sandaltzopoulos R; Karan-Djurasevic T; Mansouri L; et alii...
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma. in Blood / Blood. 2021 Jun 3;137(22):3027-3036. doi: 10.1182/blood.2020009507.
2021
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Bringhen S; Boccadoro M; Corradini P; Tacchetti P; Caravita di Toritto T; Patriarca F; Cellini C; Monaco F; Pompa A; Rota-Scalabrini D; Bernardini A; Marasca R; Antonioli E; Giuliani N; Galli M; Tosi P; Benevolo G; Capra A; Gaidano G; Cascavilla N; Offidani M; D'Agostino M; Bonello F; Larocca A;
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. in Cancers / Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.
2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
Trentin L; Gentile G; Girmenia C; Martelli M; Gaidano G; Foà R; Cuneo A; Tedeschi A; Molica S; Coscia M; Noto A; Guarente V; Stelitano C; Del Poeta G; Giordano A; Rigolin GM; De Paoli L; Murru R; Gentile M; Levato L; Ielo C; Laurenti L; Ciolli S; Vitale C; Frustaci AM; Chiarenza A; Sportoletti P; Reda G; Visentin A; et alii...
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Boccadoro M; Mauro FR; Foà R; Tedeschi A; Scarfò L; Gaidano G; Trentin L; Cuneo A; Orsucci L; Reda G; Perutelli F; De Paoli L; Montalbano MC; Boccellato E; Gentile M; Rivela P; Marchetti M; Pennese E; Rigolin GM; Murru R; Laurenti L; Cassin R; Vassallo F; Visentin A; Zamprogna G; Schiattone L; Griggio V; Porrazzo M; Vitale C; et alii...
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications. in Cancer journal (Sudbury, Mass.) / Cancer J. 2021 Jul-Aug 01;27(4):266-274. doi: 10.1097/PPO.0000000000000534.
2021
AOU Novara
Moia R; Patriarca A; Schipani M; Gaidano G;
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Jul 1;27(13):3695-3703. doi: 10.1158/1078-0432.CCR-21-0134. Epub 2021 Apr 29.
2021
AOU Città della Salute di Torino
AOU Novara
Gay F; Boccadoro M; Spencer A; Sonneveld P; Musto P; Hájek R; Gaidano G; Nagler A; Benevolo G; Belotti A; Patriarca F; Mina R; Cascavilla N; Ruggeri M; de Fabritiis P; Liberati AM; Mannina D; Capra A; Romano A; Corradini P; Offidani M; Petrucci MT; Zaccaria GM; Bertamini L;
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Sportoletti P; Laurenti L; Gattei V; Gaidano G; Polliack A; Foà R; Rossi D; Cuneo A; Di Raimondo F; Rigolin GM; Bomben R; Biagi A; Del Giudice I; Angeletti I; Rago A; Arrigo G; Vigna E; Botta C; Tripepi G; Fraticelli V; Zucchetto A; Scortechini I; Loseto G; Consoli U; Rossi FM; Pietrasanta D; Murru R; Chiarenza A; Condoluci A; et alii...
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.
2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Ordine Mauriziano
AO Alessandria
AOU Novara
Cuneo A; Foà R; Fazi P; Neri A; Guarini A; Rigolin GM; Piciocchi A; Nanni M; Raponi S; Ruocco V; Murru R; Della Starza I; De Propris MS; Del Giudice I; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Gentile M; Tani M; Musuraca G; Gottardi D; Zinzani PL; Molinari A; Gozzetti A; Re F; Orsucci L; Liberati AM; Ilariucci F; et alii...
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3.
2021
AOU Novara
Tabernero J; Pinato DJ; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; et alii...
IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC. in Hematological oncology / Hematol Oncol. 2021 Dec;39(5):707-711. doi: 10.1002/hon.2915. Epub 2021 Aug 25.
2021
AOU Novara
Benatti S; Atene CG; Fiorcari S; Mesini N; Martinelli S; Zucchini P; Bacchelli F; Maccaferri M; Debbia G; Potenza L; Rossi D; Vallisa D; Trentin L; Gaidano G; Luppi M; Marasca R; Maffei R;
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Polliack A; Trentin L; Cuneo A; Gaidano G; Di Raimondo F; Rossi D; Olivieri J; Jaksic O; Bomben R; Neri A; Fronza G; Rago A; Angeletti I; Cutrona G; Del Giudice I; Biagi A; Galimberti S; D'Arrigo G; Al-Janazreh H; Martino EA; Vigna E; Tripepi G; Zucchetto A; Rossi FM; Recchia AG; et alii...
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
D Arrigo G; Murru R; Gentile M; Gattei V; Polliack A; Trentin L; Gaidano G; Di Raimondo F; Cuneo A; Cutrona G; Rossi D; Menichini P; Olivieri J; Fronza G; Monti P; Del Giudice I; Bomben R; Neri A; Angeletti I; Biagi A; Rago A; Martino EA; Cassin R; Galimberti S; Foà R; Ferrarini M; Scortechini I; Rossi FM; Zucchetto A; et alii...
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.
2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Montillo M; Foà R; Cuneo A; Gentile M; Crea E; Marasca R; Marchetti M; Vignetti M; Mauro FR; Laurenti L; Quaglia FM; Pietrasanta D; Molinari AL; Sportoletti P; Paolini R; Varettoni M; Gaidano G; Murru R; Vitagliano O; Coscia M; Farina L; Cibien F; Zamprogna G; Reda G; Arena V; Visentin A; Piciocchi A; Cavazzini F; Rigolin GM; et alii...
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. in Blood cancer journal / Blood Cancer J. 2021 Apr 12;11(4):73. doi: 10.1038/s41408-021-00464-w.
2021
AOU San Luigi di Orbassano
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara
Bringhen S; Sonneveld P; Boccadoro M; Musto P; Hájek R; Corradini P; Guglielmelli T; Giuliani N; Aitoro G; Di Raimondo F; Bonello F; Benevolo G; Patriarca F; Innao V; de Fabritiis P; Zambello R; Cascavilla N; Liberati AM; Gaidano G; Petrucci MT; Derudas D; Capra A; Offidani M; Larocca A; D'Agostino M;
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies. in Haematologica / Haematologica. 2021 Apr 1;106(4):1079-1085. doi: 10.3324/haematol.2019.243428.
2021
AOU Città della Salute di Torino
AOU Novara
Bringhen S; Boccadoro M; Omedé P; Gaidano G; Palumbo A; Montefusco V; Cavo M; Siniscalchi A; Gilestro M; Galieni P; Capra A; Benevolo G; Olivieri A; Musto P; Ballanti S; Liberati AM; Conticello C; Petrucci MT; Bonello F; Mina R;
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases. in European journal of haematology / Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Jaksic O; Monti P; Cutrona G; Bomben R; Neri A; Fronza G; Menichini P; Biagi A; Del Giudice I; Angeletti I; Rago A; Galimberti S; Cassin R; D'Arrigo G; Mendicino F; Martino EA; Vigna E; Al-Janazreh H; Zucchetto A; et alii...
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19. in Disease markers / Dis Markers. 2021 May 13;2021:8863053. doi: 10.1155/2021/8863053. eCollection 2021.
2021
AO Alessandria
ASL Vercelli
AOU Novara
Zeppegno P; Zottarelli F; Zavattaro E; Vassia V; Zagaria D; Vaschetto R; Tarantino V; Tonello S; Tillio PA; Spinoni E; Smirne C; Savoia P; Sciarra M; Schimmenti A; Scotti L; Salamina L; Saraceno M; Santagostino M; Roveta A; Rigamonti C; Rizzi E; Rognoni A; Re R; Ragazzoni L; Percivale I; Paschè A; Patrucco F; Patti G; Pau A; et alii...
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms. in Frontiers in oncology / Front Oncol. 2021 Oct 26;11:777730. doi: 10.3389/fonc.2021.777730. eCollection 2021.
2021
AOU Novara
Moia R; Cittone MG; Boggione P; Manfredi GF; Favini C; Awikeh B; Pedrinelli AR; Mahmoud AM; Nicolosi M; Bellan M; Sainaghi PP; Pirisi M; Gaidano G; Patriarca A; Rigamonti C;
Atypical Chronic Myeloid Leukemia: Where Are We Now? in International journal of molecular sciences / Int J Mol Sci. 2020 Sep 18;21(18):6862. doi: 10.3390/ijms21186862.
2020
AOU Novara
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A;
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. in Blood cancer journal / Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3.
2020
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
AOU Novara
Gattei V; Morabito F; Ferrarini M; Gaidano G; Cuneo A; Foà R; Trentin L; Fronza G; Cutrona G; Di Raimondo F; Angeletti I; Bomben R; Neri A; D'Arrigo G; Tripepi G; Vitale C; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Loseto G; Pietrasanta D; Bossio S; Moia R; Recchia AG; Lucia E; Mendicino F; Vigna E; et alii...
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. in Scientific reports / Sci Rep. 2020 Nov 26;10(1):20731. doi: 10.1038/s41598-020-77698-4.
2020
ASL Vercelli
AO Alessandria
AOU Novara
Zeppegno P; Sainaghi PP; Zottarelli F; Zavattaro E; Vaschetto R; Vassia V; Zagaria D; Tillio PA; Tarantino V; Smirne C; Spinoni E; Scotti L; Savoia P; Sciarra M; Schimmenti A; Saraceno M; Santagostino M; Rognoni A; Roveta A; Salamina L; Rigamonti C; Rizzi E; Percivale I; Re R; Pedrinelli AR; Panella M; Parisini A; Paschè A; Pau A; et alii...
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.
2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Novara
Cucci R; Vignetti M; Foà R; Ghia P; Ferrarini I; Cimino G; Cavallari M; Medina Perez A; Mauro FR; de la Serna J; Coscia M; Di Raimondo F; Molica S; Farina L; Gaidano G; Doubek M; Ilariucci F; Tedeschi A; Marchetti M; Spacek M; Trentin L; Billio A; Ujjani CS; Roeker L; Orlandi EM; Shah NN; Schuster SJ; Pu JJ; Sehgal AR; et alii...
Precision Medicine Management of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2020 Mar 10;12(3):642. doi: 10.3390/cancers12030642.
2020
AOU Novara
Moia R; Patriarca A; Schipani M; Ferri V; Favini C; Sagiraju S; Al Essa W; Gaidano G;
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.
2020
AOU Città della Salute di Torino
AOU Novara
Bertoni F; Ladetto M; Gaidano G; Cortelazzo S; Piccin A; Ferreri A; Grønbæk K; Molinari A; Santoro A; Jerkeman M; da Silva MG; Zamò A; Novero D; Paulli M; Barbero D; Kolstad A; Mahmoud AM; Schipani M; Ghione P; Favini C; Diop F; Stefoni V; Di Rocco A; Dahl C; Moia R; Kwee I; Evangelista A; Spina V; Eskelund CW; et alii...
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Jun;34(6):1721. doi: 10.1038/s41375-019-0680-9.
2020
AOU Città della Salute di Torino
AOU Novara
Packham G; Furman RR; Allan JN; Gaidano G; D'Arena G; Coscia M; Yeomans A; Gizzi K; Vaisitti T; Vitale N; Bracciamà V; Arruga F; Forconi F; Deaglio S;
Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. in Cancers / Cancers (Basel). 2020 Jul 3;12(7):1773. doi: 10.3390/cancers12071773.
2020
AOU Città della Salute di Torino
AOU Novara
Caronna R; Corsi A; Ligia S; Di Prima A; Maestrini G; Buscicchio G; Rago A; De Paoli L; Coscia M; Vitale C; Riminucci M; Nicolai E; Porrazzo M; Gaidano G; Mauro FR;
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Feb;34(2):462-477. doi: 10.1038/s41375-019-0571-0. Epub 2019 Aug 29.
2020
AOU Città della Salute di Torino
AOU Novara
Deaglio S; Packham G; Forconi F; Furman RR; Allan JN; Gaidano G; D'Arena G; Coscia M; Gizzi K; Yeomans A; Vaisitti T; Vitale N; Bracciamà V; Arruga F;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Coscia M; Boccadoro M; Gattei V; Gaidano G; Foà R; Massaia M; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Bonello L; Marchetti M; Magliulo D; Rossi D; Pozzato G; Bo MD; Bomben R; Kopecka J; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V;
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara
Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.
2019
ASL Biella
AOU Novara
Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation. in Cancer medicine / Cancer Med. 2019 May;8(5):2041-2055. doi: 10.1002/cam4.2087. Epub 2019 Apr 4.
2019
AOU Novara
Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D;
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. in Haematologica / Haematologica. 2019 Aug;104(8):1640-1647. doi: 10.3324/haematol.2018.208272. Epub 2019 Feb 7.
2019
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Di Raimondo F; Montefusco V; Di Toritto TC; Cavo M; Galieni P; Ponticelli E; Benevolo G; Spada S; Offidani M; Musto P; Ballanti S; Gaidano G; Petrucci MT; Mina R; Bringhen S; Boccadoro M; Larocca A;
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma. in British journal of haematology / Br J Haematol. 2019 Apr;185(2):330-334. doi: 10.1111/bjh.15442. Epub 2018 Jun 17.
2019
AOU Città della Salute di Torino
AOU Novara
Vitolo U; Chiappella A; Kodipad AA; Fabbri M; Diop F; Motta G; Melle F; Scellato F; Rossi M; Rossi A; Agostinelli C; Derenzini E; Gaidano G; Tarella C; Pileri S;
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. in British journal of haematology / Br J Haematol. 2019 Apr;185(1):156-159. doi: 10.1111/bjh.15405. Epub 2018 May 22.
2019
AOU Novara
Raponi S; Del Giudice I; Ilari C; Cafforio L; Messina M; Cappelli LV; Bonina S; Piciocchi A; Marinelli M; Peragine N; Mariglia P; Mauro FR; Rigolin GM; Rossi F; Bomben R; Dal Bo M; Del Poeta G; Diop F; Favini C; Rossi D; Gaidano G; Cuneo A; Gattei V; Guarini A; Foá R;
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30.
2018
AOU Novara
Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M;
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. in Blood cancer journal / Blood Cancer J. 2018 Nov 8;8(11):108. doi: 10.1038/s41408-018-0145-9.
2018
AOU Città della Salute di Torino
AOU Novara
Molinari AL; Cavallo F; Ansell SM; Spina M; Rivera CE; Pavone V; Foran JM; Congiu A; King RL; Tucci A; Reeder CB; Inghirami G; Macon WR; Gaidano G; Pederson LD; LaPlant BR; Chiappella A; Castellino A; Ciccone G; Habermann TM; Witzig TE; Vitolo U; Nowakowski GS;
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. in Haematologica / Haematologica. 2018 May;103(5):849-856. doi: 10.3324/haematol.2017.184325. Epub 2018 Feb 22.
2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Ladetto M; Cortelazzo S; Gaidano G; Wiestner A; Piccin A; Liu D; Luminari S; Arcaini L; Rigacci L; Rusconi C; Vitolo U; Omedè P; Zamò A; Evangelista A; Carella AM; Re A; Dal Bo M; D'Agaro T; Ferrero S; Bomben R; Gattei V;
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. in Cancer / Cancer. 2018 Mar 15;124(6):1251-1259. doi: 10.1002/cncr.31193. Epub 2017 Dec 12.
2018
AOU Novara
Efficace F; Cottone F; Abel G; Niscola P; Gaidano G; Bonnetain F; Anota A; Caocci G; Cronin A; Fianchi L; Breccia M; Stauder R; Platzbecker U; Palumbo GA; Luppi M; Invernizzi R; Bergamaschi M; Borin L; Di Tucci AA; Zhang H; Sprangers M; Vignetti M; Mandelli F;
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. in European journal of haematology / Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149.
2018
AOU Città della Salute di Torino
AOU Novara
Cortelezzi A; Del Poeta G; Di Raimondo F; Recchia AG; Innocenti I; Shvidel L; Vigna E; Zirlik K; Sameer PA; Chaffee KG; Tripepi G; Bairey O; Rago A; Giordano A; Angrilli F; Goldschmidt N; Ciolli S; Molica S; Chiarenza A; Herishanu Y; Coscia M; Angeletti I; Cutrona G; Del Principe MI; Laurenti L; Rossi D; Reda G; Mauro FR; Shanafelt TD; et alii...
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Feb;59(2):423-433. doi: 10.1080/10428194.2017.1339872. Epub 2017 Jun 22.
2018
AOU Novara
Maffei R; Fiorcari S; Martinelli S; Benatti S; Bulgarelli J; Rizzotto L; Debbia G; Santachiara R; Rigolin GM; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.
2018
ASL Biella
AOU Novara
Cavalli F; Gaidano G; Bertoni F; Bernasconi E; Nassi L; Kwee I; Dirnhofer S; Schmid P; Scherrer A; Staehelin C; Novak U; Battegay M; Hasse B; Darling K; Margiotta-Casaluci G; Conconi A; Zucca E;
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Dec;59(12):2904-2910. doi: 10.1080/10428194.2018.1452208. Epub 2018 Apr 4.
2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Levis A; Fanin R; Bushell K; Morin R; Alcaide M; Mann KK; Assouline S; Volpetti S; Perali G; Cavallo F; Piccaluga PP; Lenti V; Patti C; Pileri SA; Tucci A; Califano C; Zinzani PL; Chiappella A; Vitolo U; Zanni M; Ladetto M; Gaidano G; Angelucci E; Ciccone G; Evangelista A; Sabattini E; Rossi M; Zaja F; Salvi F; et alii...
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.
2018
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M;
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. in Leukemia / Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20.
2018
AOU Città della Salute di Torino
AOU Novara
Gaidano G; Del Poeta G; Cortelezzi A; Tadmor T; Shvidel L; Herishanu Y; Recchia AG; Vigna E; D'Arrigo G; Tripepi G; Innocenti I; Uccello G; Parikh SA; Chaffee KG; Cutrona G; Giordano A; Chiarenza A; Coscia M; Angrilli F; Molica S; Di Renzo N; Rossi D; Del Principe MI; Laurenti L; Ciolli S; Zirlik K; Mauro FR; Reda G; Shanafelt TD; et alii...
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Apr 1;29(4):966-972. doi: 10.1093/annonc/mdy021.
2018
AOU Novara
Raponi S; Del Giudice I; Marinelli M; Wang J; Cafforio L; Ilari C; Piciocchi A; Messina M; Bonina S; Tavolaro S; Bordyuh M; Mariglia P; Peragine N; Mauro FR; Chiaretti S; Molica S; Gentile M; Visentin A; Trentin L; Rigolin GM; Cuneo A; Diop F; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R;
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. in Leukemia / Leukemia. 2018 Apr;32(4):979-985. doi: 10.1038/leu.2017.327. Epub 2017 Nov 16.
2018
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Corradini P; Gaidano G; Petrucci MT; Offidani M; Ballanti S; De Angelis C; Musto P; Esma F; Muccio VE; Grammatico S; Liberati AM; Galieni P; Montefusco V; De Paoli L; D'Agostino M; Bringhen S; Sonneveld P; Boccadoro M;
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. in Bone marrow transplantation / Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.
2018
AO Alessandria
AOU Novara
Di Nardo E; Saraceni F; Milone G; Pastore D; Specchia G; Lanza F; Codeluppi K; Mele G; Merli F; Capria S; Musto P; Marktel S; Mengarelli A; Ciceri F; Zallio F; Pini M; Moscato T; Martino M; Pioltelli PE; Piccirillo N; Sica S; Nassi L; Gaidano G; Farina L; Corradini P; Poiani M; Pascale SP; Chiarucci M; Nuccorini R; et alii...
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia. in Oncotarget / Oncotarget. 2017 Sep 27;8(52):90013-90027. doi: 10.18632/oncotarget.21341. eCollection 2017 Oct 27.
2017
AOU Novara
Maffei R; Fiorcari S; Vaisitti T; Martinelli S; Benatti S; Debbia G; Rossi D; Zucchini P; Potenza L; Luppi M; Gaidano G; Deaglio S; Marasca R;
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. in The Lancet. Oncology / Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.
2017
AOU Città della Salute di Torino
AOU Novara
Tucci A; Cabras MG; Congiu AG; Gotti M; Castellino A; Russo E; Cascavilla N; D'Arco A; Zaja F; Rigacci L; Pavone V; Gaidano G; Merli F; Balzarotti M; Rossi G; Stelitano C; Carella AM; Evangelista A; Brusamolino E; Angelucci E; Martelli M; Chiappella A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U;
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.
2016
AO Cuneo
AOU Novara
Barbui T; Vannucchi AM; Sant'Antonio E; Griesshammer M; Carobbio A; Musolino C; Rapezzi D; Forcina A; Pungolino E; Specchia G; Hernandez-Boluda JC; Tieghi A; Ellis MH; Cacciola R; Palova M; Cattaneo D; Nichele I; Betti S; Rossi E; Gaidano G; Zetterberg E; Vianelli N; Finazzi G; Finazzi MC; Elli E; Randi ML; Alvarez-Larrán A; Iurlo A; Ruggeri M; et alii...
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. in American journal of hematology / Am J Hematol. 2016 Oct;91(10):995-1001. doi: 10.1002/ajh.24463. Epub 2016 Jul 14.
2016
AOU Città della Salute di Torino
AOU Novara
Forghieri F; Cascavilla N; Rambaldi A; Scaramucci L; Ruggeri M; Rodeghiero F; Bergamaschi M; Vincelli ID; Di Giacomo V; Simula MP; Carpenedo M; Borchiellini A; Cottone F; Santoro C; Gaidano G; Fazi P; Mandelli F; Efficace F; Petrungaro A; Ditonno P; Caocci G; Cirrincione S; Mazzucconi MG;
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study. in The Lancet. Oncology / Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5.
2016
AOU Novara
Dimopoulos MA; Moreau P; Palumbo A; Joshua D; Pour L; Hájek R; Facon T; Ludwig H; Oriol A; Goldschmidt H; Rosiñol L; Straub J; Suvorov A; Araujo C; Rimashevskaya E; Pika T; Gaidano G; Weisel K; Goranova-Marinova V; Schwarer A; Minuk L; Masszi T; Karamanesht I; Offidani M; Hungria V; Spencer A; Orlowski RZ; Gillenwater HH; Mohamed N; et alii...
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.
2016
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara
Levis A; Argnani L; Sacchetti GM; Borsatti E; Pregno P; Freilone R; Tani M; Rusconi C; Salvi F; Stelitano C; Gaidano G; Rigacci L; Pulsoni A; Pavone V; Vitolo U; Zaja F; Anastasia A; Rossi G; Brusamolino E; Bonfichi M; Ricardi U; Santoro A; Evangelista A; Ciccone G; Castagnoli A; Gioia DM; Broccoli A; Zinzani PL;
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. in Hematological oncology / Hematol Oncol. 2015 Sep;33(3):125-32. doi: 10.1002/hon.2148. Epub 2014 May 29.
2015
AOU Novara
Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U;
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. in The Lancet. Oncology / Lancet Oncol. 2015 Sep;16(9):1025-1036. doi: 10.1016/S1470-2045(15)00201-6. Epub 2015 Jul 30.
2015
AOU Novara
Ravandi F; Ritchie EK; Sayar H; Lancet JE; Craig MD; Vey N; Strickland SA; Schiller GJ; Jabbour E; Erba HP; Pigneux A; Horst HA; Recher C; Klimek VM; Cortes J; Roboz GJ; Odenike O; Thomas X; Havelange V; Maertens J; Derigs HG; Heuser M; Damon L; Powell BL; Gaidano G; Carella AM; Wei A; Hogge D; Craig AR; et alii...
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AOU Città della Salute di Torino
AOU Novara
Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients. in Leukemia research / Leuk Res. 2015 Oct;39(10):1055-9. doi: 10.1016/j.leukres.2015.07.004. Epub 2015 Jul 14.
2015
AOU Novara
Breccia M; Efficace F; Sica S; Abruzzese E; Cedrone M; Turri D; Gobbi M; Carella AM; Gozzini A; Usala E; Cavazzini F; Danise P; Tiribelli M; Binotto G; Pregno P; Bocchia M; Gaidano G; Crugnola M; Bonifacio M; Avanzini P; Celesti F; Guella A; Martino B; Annunziata M; Luciano L; Stagno F; Vallisa D; Pungolino E; Iurlo A; et alii...
Life expectancy of young adults with follicular lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2317-22. doi: 10.1093/annonc/mdv376. Epub 2015 Sep 11.
2015
ASL Biella
AOU Novara
Zucca E; Ghielmini M; Montserrat E; Lister TA; Gribben J; Cavalli F; Gaidano G; Rancoita PM; Moccia A; Bertoni F; Matthews J; Franceschetti S; Coutinho R; Lobetti-Bodoni C; Montoto S; Lopez-Guillermo A; Conconi A;
Histologic transformation in marginal zone lymphomas†. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2329-35. doi: 10.1093/annonc/mdv368. Epub 2015 Sep 23.
2015
ASL Biella
AOU Novara
Gaidano G; Zucca E; Ramponi A; Mazzucchelli L; Cavalli F; Stathis A; Moccia AA; Bertoni F; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Conconi A; Franceschetti S;
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1506-1514. doi: 10.1016/S1470-2045(15)00206-5. Epub 2015 Sep 21.
2015
AOU Novara
Efficace F; Gaidano G; Breccia M; Voso MT; Cottone F; Angelucci E; Caocci G; Stauder R; Selleslag D; Sprangers M; Platzbecker U; Ricco A; Sanpaolo G; Beyne-Rauzy O; Buccisano F; Palumbo GA; Bowen D; Nguyen K; Niscola P; Vignetti M; Mandelli F;
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. in Blood / Blood. 2015 Jan 1;125(1):111-23. doi: 10.1182/blood-2014-07-589069. Epub 2014 Nov 3.
2015
AOU Città della Salute di Torino
AOU Novara
Wolberger C; Garcia JG; Gaidano G; Rizzi M; Wang T; Inghirami G; Rossi D; Maffei R; Vaisitti T; Coscia M; Arruga F; Mazzola F; Brusa D; Serra S; Audrito V; Raffaelli N; Deaglio S;
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. in Leukemia research / Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.
2015
AOU Novara
Caocci G; Voso MT; Angelucci E; Stauder R; Cottone F; Abel G; Nguyen K; Platzbecker U; Beyne-Rauzy O; Gaidano G; Invernizzi R; Molica S; Criscuolo M; Breccia M; Lübbert M; Sanpaolo G; Buccisano F; Ricco A; Palumbo GA; Niscola P; Zhang H; Fenu S; La Nasa G; Mandelli F; Efficace F;
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. in Haematologica / Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.
2015
AOU Novara
Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA;
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia. in Leukemia & lymphoma / Leuk Lymphoma. 2015;56(9):2637-42. doi: 10.3109/10428194.2015.1012714. Epub 2015 Mar 14.
2015
AOU Città della Salute di Torino
AOU Novara
Frustaci AM; Orsucci L; Ghione P; Urbano MA; Franceschetti S; Gentile M; Ravelli E; Belsito Petrizi V; Zaja F; Visco C; Goldaniga MC; Gini G; Motta M; Varettoni M; Baratè C; Margiotta Casaluci G; Ferrero S; Benevolo G; Picardi P; Tedeschi A; Gaidano G; Vitolo U; Morra E;
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study. in Drug design, development and therapy / Drug Des Devel Ther. 2015 May 18;9:2687-94. doi: 10.2147/DDDT.S79576. eCollection 2015.
2015
AOU Novara
Cascavilla N; De Stefano V; Pane F; Pancrazzi A; Iurlo A; Gobbi M; Palandri F; Specchia G; Liberati AM; D'Adda M; Gaidano G; Fjerza R; Achenbach H; Smith J; Wilde P; Vannucchi AM;
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. in Haematologica / Haematologica. 2014 Oct;99(10):1611-7. doi: 10.3324/haematol.2014.103853. Epub 2014 Jul 11.
2014
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Bruno B; Passera R; Gaidano G; Petrucci MT; Musto P; Baldini L; Musolino C; Bringhen S; Gay F; Oddolo D; Gilestro M; Aschero S; Ruggeri M; Caltagirone S; Boccadoro M; Omedè P;
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.
2014
AOU Città della Salute di Torino
AOU Novara
Zanni M; Ciccone G; Gaudiano M; Castellino A; Congiu A; Botto B; Dreyling M; Zaccaria A; Fattori PP; Zinzani P; Salvi F; Molinari AL; Liberati AM; Ladetto M; Pavone V; Spina M; Inghirami G; Baldi I; Carella AM; Franceschetti S; Chiappella A; Vitolo U; Gaidano G; Rossi G;
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.
2014
ASL Biella
AOU Novara
Zucca E; Cavalli F; Gaidano G; Stathis A; Porro E; Kiesewetter B; Vitolo U; Martinelli G; Zinzani PL; Arcaini L; Magagnoli M; Ferreri AJ; Devizzi L; Conconi A; Raderer M; Franceschetti S;
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. in Experimental hematology / Exp Hematol. 2014 Feb;42(2):126-36.e1. doi: 10.1016/j.exphem.2013.10.007. Epub 2013 Nov 6.
2014
AOU Novara
Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;
Richter syndrome: molecular insights and clinical perspectives. in Hematological oncology / Hematol Oncol. 2009 Mar;27(1):1-10. doi: 10.1002/hon.880.
2009
AOU Novara
Rossi D; Gaidano G;
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. in British journal of haematology / Br J Haematol. 2009 Jun;146(1):64-75. doi: 10.1111/j.1365-2141.2009.07711.x. Epub 2009 May 5.
2009
AOU Novara
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F;
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):995-1004. doi: 10.1158/1078-0432.CCR-08-1630.
2009
AOU Novara
Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G;